Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park
Clin Mol Hepatol. 2015;21(3):279-286.   Published online 2015 Sep 30     DOI: https://doi.org/10.3350/cmh.2015.21.3.279
Citations to this article as recorded by Crossref logo
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals
Jagpreet Chhatwal, Ali Hajjar, Peter P. Mueller, Gizem Nemutlu, Neeti Kulkarni, Mary Linton B. Peters, Fasiha Kanwal
Clinical Gastroenterology and Hepatology.2024; 22(1): 91.     CrossRef
Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial‐level analysis
Giuseppe A. Colloca, Antonella Venturino
Cancer.2024; 130(10): 1773.     CrossRef
The impact of waiting time and delayed treatment on the outcomes of patients with hepatocellular carcinoma: A systematic review and meta-analysis
Feng Yi Cheo, Celeste Hong Fei Lim, Kai Siang Chan, Vishal Girishchandra Shelat
Annals of Hepato-Biliary-Pancreatic Surgery.2024; 28(1): 1.     CrossRef
Based on Gadolinium Ethoxybenzyl DTPA–Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma
Shaopeng Li, Kexue Deng, Jun Qiu, Peng Wang, Dawei Yin, Yiju Xie, Yongqiang Yu
Technology in Cancer Research & Treatment.2024;[Epub]     CrossRef
Quantifying the natural growth rate of hepatocellular carcinoma: A real-world retrospective study in southwestern China
Li Tu, Hong Xie, Qi Li, Ping-Gui Lei, Pei-Ling Zhao, Fan Yang, Chi Gong, Yuan-Lin Yao, Shi Zhou
World Journal of Hepatology.2024; 16(5): 800.     CrossRef
Tumor Growth in Overdrive: Detailing an Aggressive Course of Hepatocellular Carcinoma
Simardeep Singh, Thilini Delungahawatta, Marcos Wolff, Christopher J. Haas, Ned Snyder
Case Reports in Hepatology.2024;[Epub]     CrossRef
Physics-based tissue simulator to model multicellular systems: A study of liver regeneration and hepatocellular carcinoma recurrence
Luciana Melina Luque, Carlos Manuel Carlevaro, Camilo Julio Llamoza Torres, Enrique Lomba, Roeland M.H. Merks
PLOS Computational Biology.2023; 19(3): e1010920.     CrossRef
Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study
Sun Hong Yoo, Soon Sun Kim, Sang Gyune Kim, Jung Hyun Kwon, Han-Ah Lee, Yeon Seok Seo, Young Kul Jung, Hyung Joon Yim, Do Seon Song, Seong Hee Kang, Moon Young Kim, Young-Hwan Ahn, Jieun Han, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, J
Journal of Liver Cancer.2023; 23(1): 189.     CrossRef
Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study
Hongmei Zeng, Maomao Cao, Changfa Xia, Dongmei Wang, Kun Chen, Zheng Zhu, Ruiying Fu, Shaokai Zhang, Jinyi Zhou, Huadong Wang, Xianyun Qi, Shuguang Dai, Yong Chen, Zhong Sun, Hao Ding, Qingwen Li, Hui Zhao, Xuehong Zhang, Jakub Morze, John S. Ji, Feng Sun
Nature Cancer.2023; 4(9): 1382.     CrossRef
Threshold growth has a limited role in differentiating hepatocellular carcinoma from other focal hepatic lesions
Rong Lyu, Di Wang, Weijuan Hu, Zhongsong Gao, Changlu Yu, Jiao Wang, Mingge Li, Kefeng Jia
BMC Medical Imaging.2023;[Epub]     CrossRef
Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey
Hong Zhao, Aiping Zhou, Jianguo Zhou, Xinyu Bi, Shida Yan, Jing Jin, Wenqiang Wei, Muxing Li, Caifeng Gong, Qichen Chen, Zhiwen Luo, Ning Li, Rui Mao, Xiao Chen, Bo Chen, Rongshou Zheng, Jianjun Zhao, Yue Han, Zhiyu Li, Xu Che, Yuan Tang, Yongkun Sun, Zhe
HPB.2022; 24(3): 342.     CrossRef
Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk of Hepatocellular Carcinoma: A Retrospective Study
Damithri Ranathunga, Heba Osman, Nayaar Islam, Matthew D. F. McInnes, Javeria Munir, Christian B. van der Pol, Mohamed Elfaal, Cynthia Walsh
American Journal of Roentgenology.2022; 218(3): 462.     CrossRef
Focal liver lesions in cirrhosis: Role of contrast-enhanced ultrasonography
Tommaso Vincenzo Bartolotta, Angelo Randazzo, Eleonora Bruno, Adele Taibbi
World Journal of Radiology.2022; 14(4): 70.     CrossRef
Distinguishing excess mutations and increased cell death based on variant allele frequencies
Gergely Tibély, Dominik Schrempf, Imre Derényi, Gergely J. Szöllősi, Teresa M. Przytycka
PLOS Computational Biology.2022; 18(4): e1010048.     CrossRef
The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
Zobair M. Younossi, Yusuf Yilmaz, Mohamed El‐Kassas, Ajay Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez‐Sánchez, Wah Kheong Chan, Ashwani K. Singal, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian K. Price, Fatema Nader, Issah Younossi, And
Hepatology Communications.2022; 6(10): 2860.     CrossRef
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma
Maria Guarino, Valentina Cossiga, Mario Capasso, Chiara Mazzarelli, Filippo Pelizzaro, Rodolfo Sacco, Francesco Paolo Russo, Alessandro Vitale, Franco Trevisani, Giuseppe Cabibbo
Journal of Clinical Medicine.2022; 11(15): 4475.     CrossRef
How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
Islam H. Zaki, Erin Shropshire, Shuaiqi Zhang, Dong Xiao, Benjamin Wildman-Tobriner, Daniele Marin, Rajan T. Gupta, Alaattin Erkanli, Redon C. Nelson, Mustafa R. Bashir
Abdominal Radiology.2021; 46(3): 969.     CrossRef
SBRT for HCC: Overview of technique and treatment response assessment
Kimberly L. Shampain, Caitlin E. Hackett, Sohrab Towfighi, Anum Aslam, William R. Masch, Alison C. Harris, Silvia D. Chang, Kanika Khanna, Vivek Mendiratta, Ahmed M. Gabr, Dawn Owen, Mishal Mendiratta-Lala
Abdominal Radiology.2021; 46(8): 3615.     CrossRef
Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells
Bhaskar Bhattacharya, Daniel Q. Huang, Sarah Hong Hui Low, Gim Hwa Tan, Min Ji Han, Sanamerjit Singh, Benny Tang, Sheng Chun Chang, Joey Sze Yun Lim, Mohd Feroz Mohd Omar, Yock Young Dan, Richie Soong
Oncotarget.2021; 12(7): 674.     CrossRef
Exploration and time-serial validation of logistic regression models composed of multiple laboratory tests for early detection of HCV-associated hepatocellular carcinoma
Toshihiko Kobayashi, Kiyoshi Ichihara, Shuhei Goda, Isao Hidaka, Takahiro Yamasaki, Haku Ishida
Clinica Chimica Acta.2021; 521: 137.     CrossRef
Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?
Jae Hyon Park, Yong Eun Chung, Nieun Seo, Jin-Young Choi, Mi-Suk Park, Myeong-Jin Kim
Korean Journal of Radiology.2021; 22(10): 1628.     CrossRef
Influence of pretreatment tumor growth rate on objective response of hepatocellular carcinoma treated with transarterial chemoembolization
Yvonne Purcell, Riccardo Sartoris, Valérie Paradis, Valérie Vilgrain, Maxime Ronot
Journal of Gastroenterology and Hepatology.2020; 35(2): 305.     CrossRef
Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure
Pierleone Lucatelli, Gianluca De Rubeis, Luca Ginnani Corradini, Fabrizio Basilico, Michele Di Martino, Quirino Lai, Stefano Ginanni Corradini, Alessandro Cannavale, Pier Giorgio Nardis, Mario Corona, Luca Saba, Carlo Catalano, Mario Bezzi
European Journal of Radiology.2020; 124: 108806.     CrossRef
Is delayed surgery justified for patients with hepatocellular carcinoma?
Zheng-Liang Chen, Ying-Jian Liang, Hao Xing, Tian Yang
Surgery.2020; 167(6): 1023.     CrossRef
Non‐invasive liver fibrosis scores are strongly associated with liver cancer mortality in general population without liver disease
Ki‐Chul Sung, Michael P. Johnston, Mi Y. Lee, Christopher D. Byrne
Liver International.2020; 40(6): 1303.     CrossRef
Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic
J.-J. Tuech, A. Gangloff, F. Di Fiore, P. Michel, C. Brigand, K. Slim, M. Pocard, L. Schwarz
Journal of Visceral Surgery.2020; 157(3): S7.     CrossRef
Stratégie pour la pratique de la chirurgie digestive et oncologique en situation d’épidémie de COVID-19
J.-J. Tuech, A. Gangloff, F. Di Fiore, P. Michel, C. Brigand, K. Slim, M. Pocard, L. Schwarz
Journal de Chirurgie Viscérale.2020; 157(3): S6.     CrossRef
Natural history of hepatocellular carcinoma after stereotactic body radiation therapy
Mishal Mendiratta-Lala, William Masch, Dawn Owen, Anum Aslam, Chris Maurino, Theresa Devasia, Matthew J. Schipper, Neehar D. Parikh, Kyle Cuneo, Theodore S. Lawrence, Matthew S. Davenport
Abdominal Radiology.2020; 45(11): 3698.     CrossRef
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis
Piyush Nathani, Purva Gopal, Nicole Rich, Adam Yopp, Takeshi Yokoo, Binu John, Jorge Marrero, Neehar Parikh, Amit G Singal
Gut.2020; : gutjnl-2020-321040.     CrossRef
Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout?
Kyoung A. Baek, Seung Soo Kim, Hyeong Cheol Shin, Jeong Ah Hwang, Seo-Youn Choi, Woong Hee Lee, Chan Ho Park, Hyoung Nam Lee, Nam Hun Heo
Abdominal Radiology.2020; 45(9): 2705.     CrossRef
Diagnostic performance of Liver Imaging Reporting and Data System in patients at risk of both hepatocellular carcinoma and metastasis
Min Jeong Cho, Chansik An, Khalid Suliman Aljoqiman, Jin-Young Choi, Joon Seok Lim, Mi-Suk Park, Hyungjin Rhee, Myeong-Jin Kim
Abdominal Radiology.2020; 45(11): 3789.     CrossRef
Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification
Xuqi Sun, Lingling Li, Ning Lyu, Luwen Mu, Jinfa Lai, Ming Zhao
Cancer Imaging.2020;[Epub]     CrossRef
Prevention and control strategies of general surgeons under COVID-19 pandemic
Fenglin Liu, Weibin Wang, Hong Yu, Yong Wang, Wenming Wu, Xinyu Qin, Yupei Zhao
Surgery in Practice and Science.2020; 1: 100008.     CrossRef
Liver Care and Surveillance: The Global Impact of the COVID‐19 Pandemic
Hidenori Toyoda, Daniel Q. Huang, Michael H. Le, Mindie H. Nguyen
Hepatology Communications.2020; 4(12): 1751.     CrossRef
Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient‐Derived Xenograft Assays
Min Zhu, Lin Li, Tianshi Lu, Hyesun Yoo, Ji Zhu, Purva Gopal, Sam C. Wang, Matthew R. Porembka, Nicole E. Rich, Sofia Kagan, Mobolaji Odewole, Veronica Renteria, Akbar K. Waljee, Tao Wang, Amit G. Singal, Adam C. Yopp, Hao Zhu
Hepatology.2020; 72(3): 1085.     CrossRef
Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival
David D. Lee, Gonzalo Sapisochin, Neil Mehta, Andre Gorgen, Kaitlyn R. Musto, Hana Hajda, Francis Y. Yao, David O. Hodge, Rickey E. Carter, Denise M. Harnois
Transplantation.2020; 104(10): 2105.     CrossRef
Retrospective CT/MRI Texture Analysis of Rapidly Progressive Hepatocellular Carcinoma
Charissa Kim, Natasha Cigarroa, Venkateswar Surabhi, Balaji Ganeshan, Anil K. Pillai
Journal of Personalized Medicine.2020; 10(3): 136.     CrossRef
LI-RADS Imaging Criteria for HCC Diagnosis and Treatment: Emerging Evidence
Anum Aslam, Richard Kinh Gian Do, Victoria Chernyak, Mishal Mendiratta-Lala
Current Hepatology Reports.2020; 19(4): 437.     CrossRef
Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions
Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff, Mishal Mendiratta-Lala
World Journal of Hepatology.2020; 12(10): 738.     CrossRef
Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis
Nicole E. Rich, Binu V. John, Neehar D. Parikh, Ian Rowe, Neil Mehta, Gaurav Khatri, Smitha M. Thomas, Munazza Anis, Mishal Mendiratta‐Lala, Christopher Hernandez, Mobolaji Odewole, Latha T. Sundaram, Venkata R. Konjeti, Shishir Shetty, Tahir Shah, Hao Zh
Hepatology.2020; 72(5): 1654.     CrossRef

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Xuqi Sun, Dandan Hu, Yaojun Zhang, Ning Lyu, Li Xu, Qifeng Chen, Jinfa Lai, Minshan Chen, Ming Zhao
Journal of Hepatocellular Carcinoma.2020; Volume 7: 377.     CrossRef
Impact of delayed time from diagnosis to treatment on the stage of hepatocellular carcinoma
Bing Quan, Wen-Tao Yan, Wan Yee Lau, Meng-Chao Wu, Tian Yang
Hepatobiliary & Pancreatic Diseases International.2019; 18(1): 100.     CrossRef
Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up
Mishal Mendiratta-Lala, William Masch, Prasad R. Shankar, Holly E. Hartman, Matthew S. Davenport, Matthew J. Schipper, Chris Maurino, Kyle C. Cuneo, Theodore S. Lawrence, Dawn Owen
International Journal of Radiation Oncology*Biology*Physics.2019; 103(1): 169.     CrossRef
A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma
Ruben Amoros, Ruth King, Hidenori Toyoda, Takashi Kumada, Philip J. Johnson, Thomas G. Bird
METRON.2019; 77(2): 67.     CrossRef
Discrepancy between the Actual Clinical Status of Patients with Hepatocellular Carcinoma and Expectations from Hepatocellular Carcinoma Surveillance: a Single-Center Study
Nak Min Kim, Young Seok Doh, Ji Woong Jang, Seok-Hwan Kim, Hyuk Soo Eun, Jae Hyuck Jun, Sae Hee Kim, Il Hyun Baek, Sung Hee Jung
Journal of Liver Cancer.2019; 19(1): 30.     CrossRef
Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS
Shin Hye Hwang, Sumi Park, Kyunghwa Han, Jin-young Choi, Young-Nyun Park, Mi-Suk Park
Abdominal Radiology.2019; 44(9): 3078.     CrossRef
Combination Suicide Gene Delivery with an Adeno-Associated Virus Vector Encoding Inducible Caspase-9 and a Chemical Inducer of Dimerization Is Effective in a Xenotransplantation Model of Hepatocellular Carcinoma
Nusrat Khan, Sridhar Bammidi, Sourav Chattopadhyay, Giridhara R. Jayandharan
Bioconjugate Chemistry.2019; 30(6): 1754.     CrossRef
Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response
Keungmo Yang, Pil S. Sung, Young K. You, Dong G. Kim, Jung S. Oh, Ho J. Chun, Jeong W. Jang, Si H. Bae, Jong Y. Choi, Seung K. Yoon
HPB.2019; 21(12): 1718.     CrossRef
Historical Data Are Not Relevant to the Diagnostic Performance of Ultrasound in Surveillance for Hepatocellular Carcinoma
Korosh Khalili
Gastroenterology.2019; 157(3): 899.     CrossRef
Contrast-enhanced ultrasound of malignant liver lesions
Isabelle Durot, Stephanie R. Wilson, Jürgen K. Willmann
Abdominal Radiology.2018; 43(4): 819.     CrossRef
Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease
Si Eun Lee, Chansik An, Shin Hye Hwang, Jin-Young Choi, Kyunghwa Han, Myeong-Jin Kim
European Radiology.2018; 28(4): 1551.     CrossRef
Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis
Sally Ann Tran, An Le, Changqing Zhao, Joseph Hoang, Lee Ann Yasukawa, Susan Weber, Linda Henry, Mindie H Nguyen
BMJ Open Gastroenterology.2018; 5(1): e000192.     CrossRef
Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time
Toshihiko Kasahara, Akira Miyauchi, Takumi Kudo, Eijun Nishihara, Mitsuru Ito, Yasuhiro Ito, Minoru Kihara, Akihiro Miya
Journal of Thyroid Research.2018; 2018: 1.     CrossRef
Chronic Hepatitis B Infection
Lydia S. Y. Tang, Emily Covert, Eleanor Wilson, Shyam Kottilil
JAMA.2018; 319(17): 1802.     CrossRef
Screening for hepatocellular carcinoma: What is missing?
Neil J. Mehta, Aygul Dogan Celik, Marion G. Peters
Hepatology Communications.2017; 1(1): 18.     CrossRef
Imaging of hepatocellular carcinoma and image guided therapies - how we do it
Jonathon Willatt, Julie A. Ruma, Shadi F. Azar, Nara L. Dasika, F. Syed
Cancer Imaging.2017;[Epub]     CrossRef
Men with biopsy‐confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population‐based study
Lars Bossen, Henning Grønbæk, Peter Lykke Eriksen, Peter Jepsen
Liver International.2017; 37(7): 1042.     CrossRef
Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice
Prashant Pandya, Fasiha Kanwal
Hepatology Communications.2017; 1(8): 723.     CrossRef
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma
Jong Kwan Kim, Hyung-Don Kim, Mi-Jung Jun, Sung-Cheol Yun, Ju Hyun Shim, Han Chu Lee, Danbi Lee, Jihyun An, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Kang Mo Kim
Digestive Diseases and Sciences.2017; 62(10): 2923.     CrossRef
Liver Imaging Reporting and Data System: Review of Major Imaging Features
Irene Cruite, An Tang, Adrija Mamidipalli, Amol Shah, Cynthia Santillan, Claude B. Sirlin
Seminars in Roentgenology.2016; 51(4): 292.     CrossRef
Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma
Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee
Journal of Gastrointestinal Surgery.2016; 20(11): 1807.     CrossRef